Apologies, been busy, but yes attended an MST sponsored (i think) show and tell. I have some notes which i'll try to share over the next few days, however, MST will most likely have a note on CDX saying the same things.
All very positive, except delay in FDA approval. All the other vitals that will come out with Conneqt is a 1+1=5 scenario. We don't just measure the systolic and diastolic and try to provide health parameters - we also look at the waveform which tells a whole heap more. Which is why the company is able to release a many more bio-markers.
Anyway GLTAH - we're on the right bus.
General Forum, page-811
-
- There are more pages in this discussion • 900 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CDX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.88M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 265000 | 5.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.1¢ | 33080 | 1 |
View Market Depth
| Last trade - 16.12pm 12/09/2024 (20 minute delay) ? |
| CDX (ASX) Chart |
Day chart unavailable